TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2506933
log Bayes Factor = 1.94426
Chromosome 6   position 93,615,450  (GRCh37) Explore rs2506933 on Ensembl!
Variant rs2506933 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
# Top node
0.985 0.015 0.000
L60-L75 Disorders of skin appendages
0.984 0.016 0.000
Chapter XII Diseases of the skin and subcutaneous tissue
0.984 0.016 0.000
L60 Nail disorders
0.978 0.022 0.000
Chapter V Mental and behavioural disorders
0.976 0.024 0.000
Chapter VIII Diseases of the ear and mastoid process
0.975 0.025 0.000
Chapter XX External causes of morbidity and mortality
0.972 0.028 0.000
Chapter I Certain infectious and parasitic diseases
0.970 0.030 0.000
Chapter XIX Injury, poisoning and certain other consequences of external causes
0.970 0.030 0.000
F30-F39 Mood [affective] disorders
0.969 0.031 0.000
L60.0 Ingrowing nail
0.969 0.031 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.968 0.032 0.000
B35-B49 Mycoses
0.966 0.034 0.000
F32 Depressive episode
0.965 0.035 0.000
B37 Candidiasis
0.963 0.037 0.000
H80-H83 Diseases of inner ear
0.961 0.039 0.000
F32.9 Depressive episode, unspecified
0.955 0.045 0.000
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
0.955 0.045 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.950 0.050 0.000
B37.8 Candidiasis of other sites
0.946 0.054 0.000
D60-D64 Aplastic and other anaemias
0.940 0.060 0.000
D61 Other aplastic anaemias
0.934 0.066 0.000
H81 Disorders of vestibular function
0.926 0.074 0.000
D61.9 Aplastic anaemia, unspecified
0.924 0.076 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.922 0.078 0.000
F32.1 Moderate depressive episode
0.917 0.083 0.000
Y43 Primarily systemic agents
0.906 0.094 0.000
A30-A49 Other bacterial diseases
0.896 0.104 0.000
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere
0.893 0.107 0.000
L72 Follicular cysts of skin and subcutaneous tissue
0.891 0.109 0.000
L20-L30 Dermatitis and eczema
0.884 0.116 0.000
L71 Rosacea
0.882 0.118 0.000
H60-H62 Diseases of external ear
0.867 0.133 0.000
H83 Other diseases of inner ear
0.866 0.134 0.000
H81.0 Meniere's disease
0.863 0.137 0.000
Y57 Other and unspecified drugs and medicaments
0.861 0.139 0.000
B37.0 Candidal stomatitis
0.860 0.140 0.000
S50-S59 Injuries to the elbow and forearm
0.860 0.140 0.000
S90-S99 Injuries to the ankle and foot
0.860 0.140 0.000
L72.9 Follicular cyst of skin and subcutaneous tissue, unspecified
0.852 0.148 0.000
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue
0.850 0.150 0.000
Y95 Nosocomial condition
0.839 0.161 0.000
Y52 Agents primarily affecting the cardiovascular system
0.838 0.162 0.000
Y42.7 Androgens and anabolic congeners
0.836 0.164 0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors
0.831 0.169 0.000
D70-D77 Other diseases of blood and blood-forming organs
0.829 0.171 0.000
H81.1 Benign paroxysmal vertigo
0.822 0.178 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.821 0.179 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.819 0.180 0.000
B37.3 Candidiasis of vulva and vagina
0.819 0.181 0.000
Y43.3 Other antineoplastic drugs
0.819 0.181 0.000
Y48 Anaesthetics and therapeutic gases
0.816 0.184 0.000
H65-H75 Diseases of middle ear and mastoid
0.810 0.190 0.000
D61.1 Drug-induced aplastic anaemia
0.805 0.195 0.000
L60.2 Onychogryphosis
0.803 0.196 0.000
F33 Recurrent depressive disorder
0.802 0.198 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.801 0.199 0.000
L71.9 Rosacea, unspecified
0.799 0.201 0.000
H83.0 Labyrinthitis
0.797 0.203 0.000
A41 Other septicaemia
0.795 0.205 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.791 0.209 0.000
L10-L14 Bullous disorders
0.790 0.210 0.000
F80-F89 Disorders of psychological development
0.789 0.211 0.000
T15-T19 Effects of foreign body entering through natural orifice
0.788 0.211 0.000
F30 Manic episode
0.786 0.214 0.000
V40-V49 Car occupant injured in transport accident
0.785 0.215 0.000
L72.0 Epidermal cyst
0.785 0.215 0.000
D70 Agranulocytosis
0.782 0.218 0.000
L60.8 Other nail disorders
0.782 0.218 0.000
Y42.5 Other oestrogens and progestogens
0.779 0.221 0.000
W50-W64 Exposure to animate mechanical forces
0.778 0.222 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.777 0.223 0.000
H61 Other disorders of external ear
0.775 0.225 0.000
T20-T25 Burns and corrosions of external body surface, specified by site
0.775 0.225 0.000
L29 Pruritus
0.764 0.236 0.000
S70-S79 Injuries to the hip and thigh
0.762 0.238 0.000
Y43.1 Antineoplastic antimetabolites
0.759 0.240 0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.757 0.243 0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use
0.756 0.244 0.000
B50-B64 Protozoal diseases
0.756 0.244 0.000
L57 Skin changes due to chronic exposure to nonionising radiation
0.755 0.245 0.000
A49 Bacterial infection of unspecified site
0.754 0.246 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.754 0.246 0.000
S60-S69 Injuries to the wrist and hand
0.752 0.248 0.000
B49 Unspecified mycosis
0.749 0.251 0.000
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source
0.745 0.254 0.000
H80 Otosclerosis
0.740 0.260 0.000
T36 Poisoning by systemic antibiotics
0.739 0.261 0.000
B37.4 Candidiasis of other urogenital sites
0.735 0.265 0.000
H74 Other disorders of middle ear and mastoid
0.731 0.269 0.000
X20-X29 Contact with venomous animals and plants
0.730 0.270 0.000
F32.0 Mild depressive episode
0.730 0.270 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.726 0.274 0.000
Chapter II Neoplasms
0.726 0.274 0.000
S91 Open wound of ankle and foot
0.726 0.274 0.000
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes
0.724 0.276 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.724 0.276 0.000
L73 Other follicular disorders
0.724 0.276 0.000
L65 Other nonscarring hair loss
0.723 0.277 0.000
V80-V89 Other land transport accidents
0.722 0.277 0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use
0.721 0.279 0.000
Y57.9 Drug or medicament, unspecified
0.720 0.280 0.000
D62 Acute posthaemorrhagic anaemia
0.719 0.280 0.000
H65 Nonsuppurative otitis media
0.716 0.284 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.716 0.284 0.000
B35 Dermatophytosis
0.715 0.285 0.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.713 0.287 0.000
L50-L54 Urticaria and erythema
0.711 0.289 0.000
B37.9 Candidiasis, unspecified
0.711 0.289 0.000
A40 Streptococcal septicaemia
0.711 0.289 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.710 0.290 0.000
X60-X84 Intentional self-harm
0.707 0.293 0.000
T08-T14 Injuries to unspecified part of trunk, limb or body region
0.707 0.293 0.000
S51 Open wound of forearm
0.707 0.293 0.000
Chapter XVI Certain conditions originating in the perinatal period
0.706 0.294 0.000
L75 Apocrine sweat disorders
0.705 0.295 0.000
L74 Eccrine sweat disorders
0.705 0.295 0.000
L70 Acne
0.705 0.295 0.000
L68 Hypertrichosis
0.705 0.295 0.000
L67 Hair colour and hair shaft abnormalities
0.705 0.295 0.000
L66 Cicatricial alopecia [scarring hair loss]
0.705 0.295 0.000
L64 Androgenic alopecia
0.705 0.295 0.000
L63 Alopecia areata
0.705 0.295 0.000
L62 Nail disorders in diseases classified elsewhere
0.705 0.295 0.000
F60-F69 Disorders of adult personality and behaviour
0.705 0.295 0.000
S52 Fracture of forearm
0.705 0.295 0.000
L60.9 Nail disorder, unspecified
0.701 0.299 0.000
L60.5 Yellow nail syndrome
0.701 0.299 0.000
L60.4 Beau's lines
0.701 0.299 0.000
L60.3 Nail dystrophy
0.701 0.299 0.000
L60.1 Onycholysis
0.701 0.299 0.000
B20-B24 Human immunodeficiency virus [HIV] disease
0.700 0.300 0.000
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.699 0.300 0.000
F70-F79 Mental retardation
0.699 0.300 0.000
S90 Superficial injury of ankle and foot
0.698 0.302 0.000
Y35-Y36 Legal intervention and operations of war
0.697 0.303 0.000
Y10-Y34 Event of undetermined intent
0.697 0.303 0.000
Y00-Y09 Assault
0.697 0.303 0.000
X85-X99 Assault
0.697 0.303 0.000
X58-X59 Accidental exposure to other and unspecified factors
0.697 0.303 0.000
X30-X39 Exposure to forces of nature
0.697 0.303 0.000
X10-X19 Contact with heat and hot substances
0.697 0.303 0.000
X00-X09 Exposure to smoke, fire and flames
0.697 0.303 0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure
0.697 0.303 0.000
W75-W84 Other accidental threats to breathing
0.697 0.303 0.000
W65-W74 Accidental drowning and submersion
0.697 0.303 0.000
V98-V99 Other and unspecified transport accidents
0.697 0.303 0.000
V95-V97 Air and space transport accidents
0.697 0.303 0.000
V90-V94 Water transport accidents
0.697 0.303 0.000
V70-V79 Bus occupant injured in transport accident
0.697 0.303 0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident
0.697 0.303 0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident
0.697 0.303 0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident
0.697 0.303 0.000
V01-V09 Pedestrian injured in transport accident
0.697 0.303 0.000
B85-B89 Pediculosis, acariasis and other infestations
0.696 0.304 0.000
B65-B83 Helminthiases
0.696 0.304 0.000
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers
0.696 0.304 0.000
A75-A79 Rickettsioses
0.696 0.304 0.000
A70-A74 Other diseases caused by chlamydiae
0.696 0.304 0.000
A65-A69 Other spirochaetal diseases
0.696 0.304 0.000
A20-A28 Certain zoonotic bacterial diseases
0.696 0.304 0.000
A15-A19 Tuberculosis
0.696 0.304 0.000
T33-T35 Frostbite
0.696 0.304 0.000
T26-T28 Burns and corrosions confined to eye and internal organs
0.696 0.304 0.000
T00-T07 Injuries involving multiple body regions
0.696 0.304 0.000
F38 Other mood [affective] disorders
0.695 0.305 0.000
F34 Persistent mood [affective] disorders
0.695 0.305 0.000
F39 Unspecified mood [affective] disorder
0.695 0.305 0.000
Y59 Other and unspecified vaccines and biological substances
0.694 0.306 0.000
Y58 Bacterial vaccines
0.694 0.306 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.694 0.306 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.694 0.306 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.694 0.306 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.694 0.306 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.694 0.306 0.000
D55-D59 Haemolytic anaemias
0.694 0.306 0.000
B48 Other mycoses, not elsewhere classified
0.693 0.307 0.000
B47 Mycetoma
0.693 0.307 0.000
B46 Zygomycosis
0.693 0.307 0.000
B45 Cryptococcosis
0.693 0.307 0.000
B43 Chromomycosis and phaeomycotic abscess
0.693 0.307 0.000
B42 Sporotrichosis
0.693 0.307 0.000
B41 Paracoccidioidomycosis
0.693 0.307 0.000
B40 Blastomycosis
0.693 0.307 0.000
B39 Histoplasmosis
0.693 0.307 0.000
B38 Coccidioidomycosis
0.693 0.307 0.000
B36 Other superficial mycoses
0.693 0.307 0.000
L21 Seborrhoeic dermatitis
0.693 0.307 0.000
F32.8 Other depressive episodes
0.692 0.308 0.000
F33.9 Recurrent depressive disorder, unspecified
0.691 0.309 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.691 0.309 0.000
B37.7 Candidal septicaemia
0.691 0.309 0.000
B37.6 Candidal endocarditis
0.691 0.309 0.000
B37.5 Candidal meningitis
0.691 0.309 0.000
B37.2 Candidiasis of skin and nail
0.691 0.309 0.000
B37.1 Pulmonary candidiasis
0.691 0.309 0.000
H82 Vertiginous syndromes in diseases classified elsewhere
0.689 0.311 0.000
Chapter XXII Codes for special purposes
0.689 0.311 0.000
T66-T78 Other and unspecified effects of external causes
0.688 0.312 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.687 0.313 0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities
0.687 0.313 0.000
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis
0.686 0.313 0.000
T79-T79 Certain early complications of trauma
0.686 0.314 0.000
Y57.5 X-ray contrast media
0.686 0.314 0.000
X50-X57 Overexertion, travel and privation
0.685 0.315 0.000
Y60-Y69 Misadventures to patients during surgical and medical care
0.684 0.316 0.000
L30 Other dermatitis
0.684 0.316 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.683 0.317 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.683 0.317 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.681 0.318 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.681 0.319 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.681 0.319 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.681 0.319 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.681 0.319 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.681 0.319 0.000
A41.1 Septicaemia due to other specified staphylococcus
0.680 0.320 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.680 0.320 0.000
D80-D89 Certain disorders involving the immune mechanism
0.680 0.320 0.000
D63 Anaemia in chronic diseases classified elsewhere
0.679 0.321 0.000
F52 Sexual dysfunction, not caused by organic disorder or disease
0.678 0.322 0.000
D37-D48 Neoplasms of uncertain or unknown behaviour
0.678 0.322 0.000
S92 Fracture of foot, except ankle
0.678 0.322 0.000
T29-T32 Burns and corrosions of multiple and unspecified body regions
0.678 0.322 0.000
S52.6 Fracture of lower end of both ulna and radius
0.677 0.323 0.000
A48 Other bacterial diseases, not elsewhere classified
0.676 0.324 0.000
Y43.4 Immunosuppressive agents
0.676 0.324 0.000
Y57.8 Other drugs and medicaments
0.676 0.324 0.000
B99-B99 Other infectious diseases
0.674 0.325 0.000
D60 Acquired pure red cell aplasia [erythroblastopenia]
0.674 0.326 0.000
A50-A64 Infections with a predominantly sexual mode of transmission
0.674 0.326 0.000
F50 Eating disorders
0.672 0.328 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.672 0.328 0.000
F81 Specific developmental disorders of scholastic skills
0.671 0.329 0.000
X40-X49 Accidental poisoning by and exposure to noxious substances
0.671 0.329 0.000
L28 Lichen simplex chronicus and prurigo
0.670 0.330 0.000
D61.8 Other specified aplastic anaemias
0.670 0.330 0.000
D61.3 Idiopathic aplastic anaemia
0.670 0.330 0.000
D61.2 Aplastic anaemia due to other external agents
0.670 0.330 0.000
D61.0 Constitutional aplastic anaemia
0.670 0.330 0.000
S10-S19 Injuries to the neck
0.669 0.331 0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.665 0.335 0.000
A41.8 Other specified septicaemia
0.665 0.335 0.000
H81.9 Disorder of vestibular function, unspecified
0.664 0.336 0.000
H81.8 Other disorders of vestibular function
0.664 0.336 0.000
H81.4 Vertigo of central origin
0.664 0.336 0.000
H81.3 Other peripheral vertigo
0.664 0.336 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.663 0.337 0.000
H81.2 Vestibular neuronitis
0.663 0.337 0.000
E16 Other disorders of pancreatic internal secretion
0.663 0.337 0.000
F32.3 Severe depressive episode with psychotic symptoms
0.662 0.338 0.000
L71.1 Rhinophyma
0.662 0.338 0.000
Y48.3 Local anaesthetics
0.661 0.338 0.000
Y42.9 Other and unspecified hormone antagonists
0.661 0.339 0.000
Y42.4 Oral contraceptives
0.661 0.339 0.000
Y42.2 Antithyroid drugs
0.661 0.339 0.000
Y42.1 Thyroid hormones and substitutes
0.661 0.339 0.000
H60 Otitis externa
0.661 0.339 0.000
S56 Injury of muscle and tendon at forearm level
0.661 0.339 0.000
A41.5 Septicaemia due to other Gram-negative organisms
0.659 0.341 0.000
L57.0 Actinic keratosis
0.658 0.342 0.000
S52.60 Fracture of lower end of both ulna and radius (closed)
0.658 0.342 0.000
Y54.5 Other diuretics
0.657 0.343 0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders
0.657 0.343 0.000
F30.0 Hypomania
0.655 0.345 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.654 0.346 0.000
Y48.4 Anaesthetic, unspecified
0.654 0.346 0.000
T92 Sequelae of injuries of upper limb
0.653 0.347 0.000
L11 Other acantholytic disorders
0.652 0.348 0.000
B90-B94 Sequelae of infectious and parasitic diseases
0.651 0.349 0.000
W20-W49 Exposure to inanimate mechanical forces
0.650 0.350 0.000
Y43.9 Primarily systemic agent, unspecified
0.649 0.350 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.649 0.350 0.000
Y43.6 Enzymes, not elsewhere classified
0.649 0.350 0.000
Y43.5 Acidifying and alkalising agents
0.649 0.350 0.000
Y43.2 Antineoplastic natural products
0.649 0.350 0.000
Y43.0 Antiallergic and antiemetic drugs
0.649 0.350 0.000
E16.2 Hypoglycaemia, unspecified
0.648 0.352 0.000
B44 Aspergillosis
0.648 0.352 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.646 0.354 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.646 0.354 0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms
0.646 0.354 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.646 0.354 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.644 0.356 0.000
A44 Bartonellosis
0.642 0.358 0.000
A43 Nocardiosis
0.642 0.358 0.000
A42 Actinomycosis
0.642 0.358 0.000
A39 Meningococcal infection
0.642 0.358 0.000
A37 Whooping cough
0.642 0.358 0.000
A36 Diphtheria
0.642 0.358 0.000
A32 Listeriosis
0.642 0.358 0.000
A31 Infection due to other mycobacteria
0.642 0.358 0.000
A30 Leprosy [Hansen's disease]
0.642 0.358 0.000
A38 Scarlet fever
0.642 0.358 0.000
A35 Other tetanus
0.642 0.358 0.000
A34 Obstetrical tetanus
0.642 0.358 0.000
A33 Tetanus neonatorum
0.642 0.358 0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites
0.642 0.358 0.000
H61.0 Perichondritis of external ear
0.641 0.359 0.000
Y90 Evidence of alcohol involvement determined by blood alcohol level
0.640 0.360 0.000
Y98 Lifestyle-related condition
0.640 0.360 0.000
Y97 Environmental-pollution-related condition
0.640 0.360 0.000
Y96 Work-related condition
0.640 0.360 0.000
B15-B19 Viral hepatitis
0.639 0.360 0.000
L72.2 Steatocystoma multiplex
0.639 0.361 0.000
L29.9 Pruritus, unspecified
0.635 0.365 0.000
F17 Mental and behavioural disorders due to use of tobacco
0.635 0.365 0.000
L25 Unspecified contact dermatitis
0.633 0.366 0.000
L24 Irritant contact dermatitis
0.633 0.366 0.000
L23 Allergic contact dermatitis
0.633 0.366 0.000
L20 Atopic dermatitis
0.633 0.366 0.000
L26 Exfoliative dermatitis
0.633 0.366 0.000
L22 Diaper [napkin] dermatitis
0.633 0.366 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.633 0.366 0.000
S51.9 Open wound of forearm, part unspecified
0.633 0.367 0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.633 0.367 0.000
A80-A89 Viral infections of the central nervous system
0.632 0.367 0.000
L71.8 Other rosacea
0.632 0.367 0.000
L71.0 Perioral dermatitis
0.632 0.367 0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue
0.631 0.369 0.000
E20-E35 Disorders of other endocrine glands
0.629 0.371 0.000
S20-S29 Injuries to the thorax
0.627 0.373 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.626 0.374 0.000
Y91 Evidence of alcohol involvement determined by level of intoxication
0.625 0.375 0.000
B25-B34 Other viral diseases
0.625 0.375 0.000
H61.1 Non-infective disorders of pinna
0.624 0.376 0.000
V48 Car occupant injured in noncollision transport accident
0.623 0.377 0.000
S50 Superficial injury of forearm
0.622 0.378 0.000
H62 Disorders of external ear in diseases classified elsewhere
0.622 0.378 0.000
T17 Foreign body in respiratory tract
0.621 0.379 0.000
H83.9 Disease of inner ear, unspecified
0.621 0.379 0.000
H83.8 Other specified diseases of inner ear
0.621 0.379 0.000
H83.3 Noise effects on inner ear
0.621 0.379 0.000
H83.2 Labyrinthine dysfunction
0.621 0.379 0.000
H83.1 Labyrinthine fistula
0.621 0.379 0.000
H74.3 Other acquired abnormalities of ear ossicles
0.620 0.380 0.000
W60 Contact with plant thorns and spines and sharp leaves
0.619 0.380 0.000
H74.4 Polyp of middle ear
0.619 0.380 0.000
Y57.7 Vitamins, not elsewhere classified
0.617 0.383 0.000
Y57.6 Other diagnostic agents
0.617 0.383 0.000
Y57.4 Pharmaceutical excipients
0.617 0.383 0.000
Y57.3 Alcohol deterrents
0.617 0.383 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.617 0.383 0.000
Y57.1 Lipotropic drugs
0.617 0.383 0.000
Y57.0 Appetite depressants [anorectics]
0.617 0.383 0.000
S59 Other and unspecified injuries of forearm
0.617 0.383 0.000
S58 Traumatic amputation of forearm
0.617 0.383 0.000
S57 Crushing injury of forearm
0.617 0.383 0.000
S55 Injury of blood vessels at forearm level
0.617 0.383 0.000
S54 Injury of nerves at forearm level
0.617 0.383 0.000
S53 Dislocation, sprain and strain of joints and ligaments of elbow
0.617 0.383 0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs
0.617 0.383 0.000
A49.1 Streptococcal infection, unspecified
0.617 0.383 0.000
S98 Traumatic amputation of ankle and foot
0.616 0.383 0.000
S97 Crushing injury of ankle and foot
0.616 0.383 0.000
S96 Injury of muscle and tendon at ankle and foot level
0.616 0.383 0.000
S95 Injury of blood vessels at ankle and foot level
0.616 0.383 0.000
S94 Injury of nerves at ankle and foot level
0.616 0.383 0.000
T18 Foreign body in alimentary tract
0.615 0.385 0.000
D76 Certain diseases involving lymphoreticular tissue and reticulohistiocytic system
0.615 0.385 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.613 0.387 0.000
T21 Burn and corrosion of trunk
0.613 0.387 0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx
0.613 0.387 0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.612 0.388 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.612 0.388 0.000
V20-V29 Motorcycle rider injured in transport accident
0.612 0.388 0.000
H61.3 Acquired stenosis of external ear canal
0.611 0.389 0.000
L59 Other disorders of skin and subcutaneous tissue related to radiation
0.610 0.390 0.000
L58 Radiodermatitis
0.610 0.390 0.000
L56 Other acute skin changes due to ultraviolet radiation
0.610 0.390 0.000
L55 Sunburn
0.610 0.390 0.000
F99-F99 Unspecified mental disorder
0.609 0.391 0.000
S80-S89 Injuries to the knee and lower leg
0.608 0.392 0.000
S79 Other and unspecified injuries of hip and thigh
0.607 0.393 0.000
H65.3 Chronic mucoid otitis media
0.606 0.394 0.000
L57.8 Other skin changes due to chronic exposure to nonionising radiation
0.603 0.397 0.000
A49.0 Staphylococcal infection, unspecified
0.603 0.397 0.000
B59 Pneumocystosis
0.603 0.397 0.000
S70 Superficial injury of hip and thigh
0.602 0.398 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.601 0.399 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.601 0.399 0.000
Y52.7 Peripheral vasodilators
0.601 0.399 0.000
Y52.1 Calcium-channel blockers
0.601 0.399 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.601 0.399 0.000
Y53.1 Other antacids and anti-gastric-secretion drugs
0.600 0.400 0.000
S93 Dislocation, sprain and strain of joints and ligaments at ankle and foot level
0.599 0.401 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.598 0.401 0.000
H73 Other disorders of tympanic membrane
0.598 0.402 0.000
H61.8 Other specified disorders of external ear
0.598 0.402 0.000
L27 Dermatitis due to substances taken internally
0.597 0.403 0.000
F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified
0.596 0.404 0.000
F51 Nonorganic sleep disorders
0.596 0.404 0.000
F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors
0.596 0.404 0.000
F55 Abuse of non-dependence-producing substances
0.596 0.404 0.000
F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere
0.596 0.404 0.000
S91.0 Open wound of ankle
0.596 0.404 0.000
D74 Methaemoglobinaemia
0.595 0.405 0.000
D77 Other disorders of blood and blood-forming organs in diseases classified elsewhere
0.595 0.405 0.000
D71 Functional disorders of polymorphonuclear neutrophils
0.595 0.405 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.594 0.406 0.000
L72.8 Other follicular cysts of skin and subcutaneous tissue
0.594 0.406 0.000
V44 Car occupant injured in collision with heavy transport vehicle or bus
0.593 0.407 0.000
L29.8 Other pruritus
0.591 0.409 0.000
S64 Injury of nerves at wrist and hand level
0.591 0.409 0.000
D63.0 Anaemia in neoplastic disease
0.590 0.410 0.000
S99 Other and unspecified injuries of ankle and foot
0.589 0.410 0.000
F00-F09 Organic, including symptomatic, mental disorders
0.589 0.411 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.588 0.411 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.588 0.411 0.000
T42.3 Barbiturates
0.588 0.411 0.000
T42.2 Succinimides and oxazolidinediones
0.588 0.411 0.000
T42.1 Iminostilbenes
0.588 0.411 0.000
T42.0 Hydantoin derivatives
0.588 0.411 0.000
L29.2 Pruritus vulvae
0.588 0.411 0.000
H61.9 Disorder of external ear, unspecified
0.588 0.412 0.000
T36.0 Penicillins
0.588 0.412 0.000
T39.1 4-Aminophenol derivatives
0.588 0.412 0.000
T38.9 Other and unspecified hormone antagonists
0.588 0.412 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.588 0.412 0.000
T38.7 Androgens and anabolic congeners
0.588 0.412 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.588 0.412 0.000
T38.5 Other oestrogens and progestogens
0.588 0.412 0.000
T38.4 Oral contraceptives
0.588 0.412 0.000
T38.2 Antithyroid drugs
0.588 0.412 0.000
T38.1 Thyroid hormones and substitutes
0.588 0.412 0.000
T38.0 Glucocorticoids and synthetic analogues
0.588 0.412 0.000
A41.0 Septicaemia due to Staphylococcus aureus
0.588 0.412 0.000
S73 Dislocation, sprain and strain of joint and ligaments of hip
0.587 0.412 0.000
F81.9 Developmental disorder of scholastic skills, unspecified
0.587 0.413 0.000
T23 Burn and corrosion of wrist and hand
0.586 0.414 0.000
Y48.5 Therapeutic gases
0.585 0.415 0.000
Y48.2 Other and unspecified general anaesthetics
0.585 0.415 0.000
Y48.1 Parenteral anaesthetics
0.585 0.415 0.000
Y48.0 Inhaled anaesthetics
0.585 0.415 0.000
C78.0 Secondary malignant neoplasm of lung
0.585 0.415 0.000
D72 Other disorders of white blood cells
0.582 0.418 0.000
H80.9 Otosclerosis, unspecified
0.582 0.418 0.000
W55 Bitten or struck by other mammals
0.581 0.419 0.000
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere
0.581 0.419 0.000
H70 Mastoiditis and related conditions
0.581 0.419 0.000
H68 Eustachian salpingitis and obstruction
0.581 0.419 0.000
H67 Otitis media in diseases classified elsewhere
0.581 0.419 0.000
Y40 Systemic antibiotics
0.580 0.420 0.000
Y44 Agents primarily affecting blood constituents
0.579 0.421 0.000
A40.8 Other streptococcal septicaemia
0.578 0.422 0.000
Y54.3 Benzothiadiazine derivatives
0.577 0.423 0.000
S91.1 Open wound of toe(s) without damage to nail
0.577 0.423 0.000
H74.8 Other specified disorders of middle ear and mastoid
0.576 0.424 0.000
F33.8 Other recurrent depressive disorders
0.575 0.425 0.000
F33.4 Recurrent depressive disorder, currently in remission
0.575 0.425 0.000
F33.0 Recurrent depressive disorder, current episode mild
0.575 0.425 0.000
S68 Traumatic amputation of wrist and hand
0.575 0.425 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.574 0.426 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.574 0.426 0.000
T46.7 Peripheral vasodilators
0.574 0.426 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.574 0.426 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.574 0.426 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.574 0.426 0.000
T46.1 Calcium-channel blockers
0.574 0.426 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.574 0.426 0.000
S63 Dislocation, sprain and strain of joints and ligaments at wrist and hand level
0.574 0.426 0.000
V49 Car occupant injured in other and unspecified transport accidents
0.573 0.427 0.000
B00-B09 Viral infections characterized by skin and mucous membrane lesions
0.573 0.427 0.001
F17.2 Dependence syndrome
0.571 0.429 0.000
Q80-Q89 Other congenital malformations
0.570 0.429 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.570 0.430 0.000
A41.4 Septicaemia due to anaerobes
0.570 0.430 0.000
A41.3 Septicaemia due to Haemophilus influenzae
0.570 0.430 0.000
A41.2 Septicaemia due to unspecified staphylococcus
0.570 0.430 0.000
F52.2 Failure of genital response
0.569 0.431 0.000
Y85-Y89 Sequelae of external causes of morbidity and mortality
0.569 0.431 0.000
Y54.9 Mineral salts, not elsewhere classified
0.567 0.433 0.000
Y54.8 Agents affecting uric acid metabolism
0.567 0.433 0.000
Y54.7 Agents affecting calcification
0.567 0.433 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.567 0.433 0.000
Y54.4 Loop [high-ceiling] diuretics
0.567 0.433 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.567 0.433 0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.567 0.433 0.000
Y54.0 Mineralocorticoids
0.567 0.433 0.000
L13 Other bullous disorders
0.567 0.433 0.000
L12 Pemphigoid
0.567 0.433 0.000
L10 Pemphigus
0.567 0.433 0.000
L14 Bullous disorders in diseases classified elsewhere
0.567 0.433 0.000
F84 Pervasive developmental disorders
0.565 0.434 0.000
F89 Unspecified disorder of psychological development
0.565 0.434 0.000
F88 Other disorders of psychological development
0.565 0.434 0.000
F83 Mixed specific developmental disorders
0.565 0.434 0.000
F82 Specific developmental disorder of motor function
0.565 0.434 0.000
T19 Foreign body in genito-urinary tract
0.565 0.435 0.000
T15 Foreign body on external eye
0.565 0.435 0.000
T16 Foreign body in ear
0.565 0.435 0.000
T51 Toxic effect of alcohol
0.565 0.435 0.000
W50 Hit, struck, kicked, twisted, bitten or scratched by another person
0.564 0.436 0.000
F30.9 Manic episode, unspecified
0.564 0.436 0.000
F30.8 Other manic episodes
0.564 0.436 0.000
F30.2 Mania with psychotic symptoms
0.564 0.436 0.000
F30.1 Mania without psychotic symptoms
0.564 0.436 0.000
V47 Car occupant injured in collision with fixed or stationary object
0.563 0.437 0.000
V46 Car occupant injured in collision with other nonmotor vehicle
0.563 0.437 0.000
V45 Car occupant injured in collision with railway train or railway vehicle
0.563 0.437 0.000
V43 Car occupant injured in collision with car, pick-up truck or van
0.563 0.437 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.